186 related articles for article (PubMed ID: 32901075)
1. Administration of cardiac mesenchymal cells modulates innate immunity in the acute phase of myocardial infarction in mice.
Kang Y; Nasr M; Guo Y; Uchida S; Weirick T; Li H; Kim J; Moore JB; Muthusamy S; Bolli R; Wysoczynski M
Sci Rep; 2020 Sep; 10(1):14754. PubMed ID: 32901075
[TBL] [Abstract][Full Text] [Related]
2. Cardiac mesenchymal cells from failing and nonfailing hearts limit ventricular dilation when administered late after infarction.
Audam TN; Nong Y; Tomlin A; Jurkovic A; Li H; Zhu X; Long BW; Zheng YW; Weirick T; Brittian KR; Riggs DW; Gumpert A; Uchida S; Guo Y; Wysoczynski M; Jones SP
Am J Physiol Heart Circ Physiol; 2020 Jul; 319(1):H109-H122. PubMed ID: 32442025
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Cardiogenic Factors on Cardiac Mesenchymal Cell Anti-Fibrogenic Paracrine Signaling and Therapeutic Performance.
Heidel JS; Fischer AG; Tang XL; Sadri G; Wu WJ; Moisa CR; Stowers H; Sandella N; Wysoczynski M; Uchida S; Moore Iv JB
Theranostics; 2020; 10(4):1514-1530. PubMed ID: 32042319
[TBL] [Abstract][Full Text] [Related]
4. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.
Dong F; Harvey J; Finan A; Weber K; Agarwal U; Penn MS
Circulation; 2012 Jul; 126(3):314-24. PubMed ID: 22685115
[TBL] [Abstract][Full Text] [Related]
5. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
[TBL] [Abstract][Full Text] [Related]
6. Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction.
Guo Y; Wysoczynski M; Nong Y; Tomlin A; Zhu X; Gumpert AM; Nasr M; Muthusamy S; Li H; Book M; Khan A; Hong KU; Li Q; Bolli R
Basic Res Cardiol; 2017 Mar; 112(2):18. PubMed ID: 28210871
[TBL] [Abstract][Full Text] [Related]
7. Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms.
Santos Nascimento D; Mosqueira D; Sousa LM; Teixeira M; Filipe M; Resende TP; Araújo AF; Valente M; Almeida J; Martins JP; Santos JM; Bárcia RN; Cruz P; Cruz H; Pinto-do-Ó P
Stem Cell Res Ther; 2014 Jan; 5(1):5. PubMed ID: 24411922
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts.
Lima Correa B; El Harane N; Gomez I; Rachid Hocine H; Vilar J; Desgres M; Bellamy V; Keirththana K; Guillas C; Perotto M; Pidial L; Alayrac P; Tran T; Tan S; Hamada T; Charron D; Brisson A; Renault NK; Al-Daccak R; Menasché P; Silvestre JS
Cardiovasc Res; 2021 Jan; 117(1):292-307. PubMed ID: 32049348
[TBL] [Abstract][Full Text] [Related]
9. Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair.
Mehra P; Guo Y; Nong Y; Lorkiewicz P; Nasr M; Li Q; Muthusamy S; Bradley JA; Bhatnagar A; Wysoczynski M; Bolli R; Hill BG
Basic Res Cardiol; 2018 Oct; 113(6):46. PubMed ID: 30353243
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.
Li TS; Cheng K; Malliaras K; Smith RR; Zhang Y; Sun B; Matsushita N; Blusztajn A; Terrovitis J; Kusuoka H; Marbán L; Marbán E
J Am Coll Cardiol; 2012 Mar; 59(10):942-53. PubMed ID: 22381431
[TBL] [Abstract][Full Text] [Related]
11. Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy.
Moore JB; Tang XL; Zhao J; Fischer AG; Wu WJ; Uchida S; Gumpert AM; Stowers H; Wysoczynski M; Bolli R
Basic Res Cardiol; 2018 Nov; 114(1):3. PubMed ID: 30446837
[TBL] [Abstract][Full Text] [Related]
12. Iron Regulator Hepcidin Impairs Macrophage-Dependent Cardiac Repair After Injury.
Zlatanova I; Pinto C; Bonnin P; Mathieu JRR; Bakker W; Vilar J; Lemitre M; Voehringer D; Vaulont S; Peyssonnaux C; Silvestre JS
Circulation; 2019 Mar; 139(12):1530-1547. PubMed ID: 30586758
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction.
Shafei AE; Ali MA; Ghanem HG; Shehata AI; Abdelgawad AA; Handal HR; Talaat KA; Ashaal AE; El-Shal AS
J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29044850
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix remodeling following myocardial infarction influences the therapeutic potential of mesenchymal stem cells.
Sullivan KE; Quinn KP; Tang KM; Georgakoudi I; Black LD
Stem Cell Res Ther; 2014 Jan; 5(1):14. PubMed ID: 24460869
[TBL] [Abstract][Full Text] [Related]
15. Harnessing the early post-injury inflammatory responses for cardiac regeneration.
Cheng B; Chen HC; Chou IW; Tang TW; Hsieh PC
J Biomed Sci; 2017 Jan; 24(1):7. PubMed ID: 28086885
[TBL] [Abstract][Full Text] [Related]
16. Histone Deacetylase 1 Depletion Activates Human Cardiac Mesenchymal Stromal Cell Proangiogenic Paracrine Signaling Through a Mechanism Requiring Enhanced Basic Fibroblast Growth Factor Synthesis and Secretion.
Moore JB; Zhao J; Fischer AG; Keith MCL; Hagan D; Wysoczynski M; Bolli R
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679560
[TBL] [Abstract][Full Text] [Related]
17. Nanotubular crosstalk with distressed cardiomyocytes stimulates the paracrine repair function of mesenchymal stem cells.
Figeac F; Lesault PF; Le Coz O; Damy T; Souktani R; Trébeau C; Schmitt A; Ribot J; Mounier R; Guguin A; Manier C; Surenaud M; Hittinger L; Dubois-Randé JL; Rodriguez AM
Stem Cells; 2014 Jan; 32(1):216-30. PubMed ID: 24115309
[TBL] [Abstract][Full Text] [Related]
18. CD8
Ilatovskaya DV; Pitts C; Clayton J; Domondon M; Troncoso M; Pippin S; DeLeon-Pennell KY
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H581-H596. PubMed ID: 31322426
[TBL] [Abstract][Full Text] [Related]
19. Non-inferiority of microencapsulated mesenchymal stem cells to free cells in cardiac repair after myocardial infarction: A rationale for using paracrine factor(s) instead of cells.
Karpov AA; Puzanov MV; Ivkin DY; Krasnova MV; Anikin NA; Docshin PM; Moiseeva OM; Galagudza MM
Int J Exp Pathol; 2019 Apr; 100(2):102-113. PubMed ID: 31017330
[TBL] [Abstract][Full Text] [Related]
20. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
Lu D; Liao Y; Zhu SH; Chen QC; Xie DM; Liao JJ; Feng X; Jiang MH; He W
Stem Cell Res Ther; 2019 Apr; 10(1):127. PubMed ID: 31029167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
